Case report: A patient coinfected by Borrelia burgdorferi sensu lato and spotted fever group Rickettsiae in Urumqi, China.
Jiang, Yi PhD a,b; Hou, Xuexia MS a,b; Zhang, Lin PhD a,b; Tan, Yuhui MS c; Lu, Chen MD c; Xiao, Dong MD c; Li, Hongyan MD c; Hao, Qin PhD a,b,*; Wan, Kanglin PhD a,b,*
98(46):e17977, November 2019.
(Format: HTML, PDF)
Rationale: Both Borrelia burgdorferi sensu lato and spotted fever group Rickettsiae (SFGR) are pathogens carried by ticks. There is a possibility of co-infection with these tick-borne diseases.
Patient concerns: Male patient, 63 years-of-age, admitted to hospital with skin rash presenting for 1 week and fever with cough and expectoration for 3 days before admission.
Diagnoses: We diagnosed that the patient was co-infected by B burgdorferi sl and SFGR using laboratory test results and the patient's clinical manifestations.
Interventions: The patient started therapy with oral minocycline, then levofloxacin by intravenous injection for SFGR. Meanwhile, he was treated with penicillin G sodium, cefoperazone sulbactam sodium and ceftriaxone by intravenous injection for B burgdorferi sl.
Outcomes: After the patient was in stable condition, he was discharged from hospital.
Lessons: This case report highlights the possibility of co-infection by 2 tick-borne diseases in Urumqi, Xinjiang Uygur Autonomous Region, China. The antibiotic therapy should be based on the detection of pathogenic bacteria, and the different susceptibilities of co-infecting bacteria should be considered.
Copyright (C) 2019 The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.